BCL2 and acute myeloid leukemia: This is noteworthy since a SL interaction between Bcl-2 family members and IDH1 mutation in AML was recently identified and validated using in vitro and xenograft models27, constituting an example of a true mutation-specific SL partner emerging from the deletion pipeline in MiSL (Fig. 1b).